Free Trial

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Consensus Recommendation of "Moderate Buy" by Analysts

Sabra Healthcare REIT logo with Finance background

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven brokerages that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $19.67.

A number of research analysts have commented on SBRA shares. Scotiabank upped their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Truist Financial upped their price target on Sabra Healthcare REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research report on Tuesday, March 18th.

Read Our Latest Stock Report on Sabra Healthcare REIT

Sabra Healthcare REIT Trading Up 0.8%

SBRA traded up $0.16 during midday trading on Wednesday, reaching $18.62. 1,028,774 shares of the company's stock traded hands, compared to its average volume of 2,301,133. The firm has a fifty day moving average of $17.91 and a two-hundred day moving average of $17.32. The stock has a market capitalization of $4.43 billion, a price-to-earnings ratio of 31.55, a P/E/G ratio of 1.41 and a beta of 0.85. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.22 and a quick ratio of 4.22. Sabra Healthcare REIT has a 52 week low of $15.11 and a 52 week high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.01. The business had revenue of $183.54 million during the quarter, compared to analyst estimates of $180.23 million. Sabra Healthcare REIT had a return on equity of 5.14% and a net margin of 19.55%. Sabra Healthcare REIT's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.35 EPS. On average, equities analysts anticipate that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 annualized dividend and a yield of 6.45%. Sabra Healthcare REIT's dividend payout ratio is 203.39%.

Insider Buying and Selling

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director directly owned 64,725 shares in the company, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.20% of the company's stock.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of institutional investors and hedge funds have recently modified their holdings of the company. State of Michigan Retirement System boosted its stake in shares of Sabra Healthcare REIT by 1.1% in the 1st quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust's stock worth $990,000 after buying an additional 600 shares during the last quarter. Louisiana State Employees Retirement System boosted its stake in shares of Sabra Healthcare REIT by 0.9% in the 1st quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust's stock worth $1,158,000 after buying an additional 600 shares during the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of Sabra Healthcare REIT by 17.2% in the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after buying an additional 642 shares during the last quarter. Assetmark Inc. boosted its stake in shares of Sabra Healthcare REIT by 33.4% in the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after buying an additional 656 shares during the last quarter. Finally, Diversify Advisory Services LLC boosted its stake in shares of Sabra Healthcare REIT by 5.7% in the 1st quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust's stock worth $226,000 after buying an additional 689 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

(Get Free Report

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Read More

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines